Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents
Reference:
Leese, M. P., Jourdan, F., Ferrandis, E., Regis-Lydi, S., Kasprzyk, P. G., Stengel, C., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Optimisation of tetrahydroisoquinoline based microtubule disruptors as anti-cancer agents. EJC Supplements, 8 (7), p. 141.
Related documents:
This repository does not currently have the full-text of this item.You may be able to access a copy if URLs are provided below. (Contact Author)
Official URL:
http://dx.doi.org/10.1016/S1359-6349(10)72153-4
Details
| Item Type | Articles |
| Creators | Leese, M. P., Jourdan, F., Ferrandis, E., Regis-Lydi, S., Kasprzyk, P. G., Stengel, C., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L. |
| DOI | 10.1016/S1359-6349(10)72153-4 |
| Departments | Faculty of Science > Pharmacy & Pharmacology |
| Refereed | No |
| Status | Published |
| ID Code | 23294 |
| Additional Information | Meeting abstract from 22nd EORTC NCI AACR Symposium on Molecular Targets and Cancer Therapeutics. 16-19 November 2010. Berlin, Germany. |
Export
Actions (login required)
| View Item |
